Home > Insider Trading > Filing (0000899243-20-032771)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1731831	Eidos Therapeutics Inc.	EIDX	Pharmaceutical Preparations (2834)	463733671

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1742587	Uma Sinha	C/O Eidos Therapeutics, Inc. 101 Montgomery Street, Suite 2000 San Francisco CA 94104	Chief Scientific Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-12-02	3,798	$89.63	317,727	No	4	S	Direct
Common Stock	Disposition	2020-12-02	702	$90.63	317,025	No	4	S	Direct
Common Stock	Disposition	2020-12-02	300	$91.89	316,725	No	4	S	Direct
Common Stock	Disposition	2020-12-02	200	$92.97	316,525	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on August 13, 2020.
Represents the weighted average sale price of the shares sold ranging from $89.15 to $90.125 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 5.
Represents the weighted average sale price of the shares sold ranging from $90.33 to $91.18 per share.
Represents the weighted average sale price of the shares sold ranging from $91.56 to $92.10 per share.
Represents the weighted average sale price of the shares sold ranging from $92.71 to $93.22 per share.